Associate Director, Global Search & Evaluation

The Novo Nordisk Cambridge location is the headquarters for Global Business Development across all of our therapeutic and technology areas. We contribute to innovation in one of the world's largest life sciences ecosystems by participating in events and discussions with renowned and upcoming scientists looking for the next scientific breakthrough to bring transformative treatments to patients. We work with start-ups, established companies, venture capitalists, teaching hospitals, and academic institutions to support the development of innovation for mutual benefit, and to help patients in all of our current therapy areas.

Through a variety of partnership models, we accelerate ideas from the lab and clinic to advance and expand our product portfolio and to improve outcomes for the patients we serve

The Novo Nordisk Cambridge location is the headquarters for Global Business Development across all of our therapeutic and technology areas. We contribute to innovation in one of the world's largest life sciences ecosystems by participating in events and discussions with renowned and upcoming scientists looking for the next scientific breakthrough to bring transformative treatments to patients. We work with start-ups, established companies, venture capitalists, teaching hospitals, and academic institutions to support the development of innovation for mutual benefit, and to help patients in all of our current therapy areas.

Through a variety of partnership models, we accelerate ideas from the lab and clinic to advance and expand our product portfolio and to improve outcomes for the patients we serve

Corporate Development contributes to innovation in one of the world's largest life sciences ecosystems by participating in events and discussions with renowned and upcoming scientists–looking for the next scientific breakthrough to bring transformative treatments to patients. We work with start-ups, established companies, venture capitalists, teaching hospitals and academic institutions to support the development of innovation for mutual benefit and to help patients in all of our current therapy areas.

Through a variety of partnership models, we accelerate ideas from the lab and clinic to advance and expand our product portfolio and to improve outcomes for the patients we serve. Search & Evaluation (S&E) is part of Corporate Development and acts as the primary entry point for external drug and technology opportunities relevant to Novo Nordisk at Global Drug Discovery, Global Technology Research, Global Development and Corporate level.

S&E conducts pro‑active scouting campaigns to identify relevant opportunities by targeting universities, biotechnology companies and venture capital firms, by means of partnering events, road shows and commissioned meetings or events. The search for novel therapeutics focuses on our core areas: diabetes, obesity, as well as MASH, CVD CKD and rare blood and endocrine disorders. Besides our therapeutic areas of interest, S&E supports the identification of cutting‑edge enabling technologies within oligonucleotides, protein and peptide engineering and gene editing/therapy.

Working cross‑functionally, S&E supports the assessment of such external opportunities all the way to due diligence and contractual negotiation. The role is a driver for change in executing Novo Nordisk's strategy and business development activities on a global scale and has the following responsibilities:
Identification of novel pipeline assets and enabling technologies. Strategic overview of internal, as well as BD, pipeline assets. Evaluation of novel pipeline assets and enabling technologies.

The position is part of the global S&E team…